Viewing Study NCT00645866

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 4:08 PM

Ignite Modification Date: 2026-01-11 @ 8:28 AM

Study NCT ID: NCT00645866

Status: COMPLETED

Last Update Posted: 2011-05-16

First Post: 2008-03-27

Is Gene Therapy: True

Has Adverse Events: False

Brief Title: Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer

Sponsor: Mayo Clinic

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module